Targeting Gene Regulation in Disease

our mission

To find innovative solutions for diseases of aberrant gene control by advancing the science of RNA and chromatin regulation, developing new technological platforms, and discovering early stage therapeutics.

our vision

To build a collaborative therapeutic center dedicated to excellence in studying and drugging gene regulation.


what’s trending: CENTER NEWS AND INSIGHTS

recent media & publications

Group Leader, Dr. Calla Olson’s paper on the development of a selective CDK7 inhibitor was published in Cell Chemical Biology. Collaborators from the Nathanael Gray Lab at Dana-Farber Cancer Institute and Charles Lin Lab at Baylor College of Medicine are among contributors.

WE’re HIRING!

FACULTY POSITION IN THE BIOLOGY OF RNA AND CHROMATIN REGULATION

FACULTY POSITION IN STRUCTURE OF GENE REGULATION

upcoming events and deadlines

September 20, 2019: RNA and Chromatin Group talks resume!

October 9, 2019: Applications for faculty positions due.

 

 

therapeutic innovation center at baylor college of medicine

One Baylor Plaza
MS: BCM125
Houston, TX 77030-3411

Phone: (713) 798-2133
Email: thinc-communications@bcm.edu


To achieve our goal of translating fundamental discoveries in gene regulation into therapeutics, we will:

  • Align chemical biology, genomics, and computational biology for rigorous and focused therapeutic development

  • Recruit talented interdisciplinary scientists to rapidly discover new medicines

  • Bridge biological and chemical technology developments with the expertise of scientist and physicians at Baylor College of Medicine to impact diseases of altered gene control